ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 33 filers reported holding ASTRIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $108,371 | -10.4% | 14,527 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $121,010 | -43.2% | 14,527 | -9.4% | 0.00% | -60.0% |
| Q1 2023 | $213,159 | -10.6% | 16,027 | +0.1% | 0.01% | 0.0% |
| Q4 2022 | $238,478 | +48.1% | 16,016 | -10.1% | 0.01% | +25.0% |
| Q3 2022 | $161,000 | +126.8% | 17,816 | -24.6% | 0.00% | +100.0% |
| Q2 2022 | $71,000 | -55.1% | 23,616 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $158,000 | +33.9% | 23,616 | +8.3% | 0.00% | +50.0% |
| Q4 2021 | $118,000 | +9.3% | 21,816 | +78.1% | 0.00% | 0.0% |
| Q3 2021 | $108,000 | – | 12,249 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 1,347,088 | $17,916,270 | 9.94% |
| Fairmount Funds Management LLC | 1,901,397 | $25,288,580 | 4.35% |
| Ikarian Capital, LLC | 869,390 | $11,562,887 | 2.62% |
| Affinity Asset Advisors, LLC | 529,369 | $7,040,608 | 2.32% |
| Logos Global Management LP | 1,044,960 | $13,897,968 | 1.99% |
| Ghost Tree Capital, LLC | 450,000 | $5,985,000 | 1.77% |
| Vivo Capital, LLC | 1,681,199 | $22,359,947 | 1.55% |
| Opaleye Management Inc. | 302,000 | $4,096,400 | 1.23% |
| Tri Locum Partners LP | 275,011 | $3,657,646 | 1.11% |
| Saturn V Capital Management LP | 101,339 | $1,347,809 | 1.01% |